New Psychoactive Substances: A Canadian perspective on emerging trends and challenges for the clinical laboratory.
Clinical biochemistry December 1, 2024 Jessica J Miller, Mehrdad Yazdanpanah, David A Colantonio et al.
The production and use of New Psychoactive Substances (NPS) has skyrocketed over the last decade, causing major challenges for government authorities, public health agencies, and laboratories across the world. NPS are designed to mimic the psychoactive effects of unregulated or controlled drugs, while constantly being modified to evade drug control regulation. Hence, they are referred to as...